Pediatric Bone Marrow Transplant for Acute Lymphoblastic Leukemia (ALL)
Qu'est-ce qui est inclus dans ce forfait
Procédures Médicales
- Analyse sanguine biochimique
- Biopsie de moelle osseuse
- Ponction médullaire avec analyse cytogénétique
- Consultation avec un hématologue
- Etude cytogénétique de la moelle osseuse
- Analyse approfondie du sang
- Сonsultation avec un oncohématologue
- Diagnostic complet de la leucémie
- Greffe de moelle osseuse autologue
- Transplantation allogénique de moelle osseuse provenant d'un donneur non apparenté
- Transplantation allogénique de moelle osseuse d'un donneur apparenté
- Une greffe de moelle osseuse
- Test anti-VIH
- Test anti-HBC
- Test anti-VHCAb
- Des analyses de sang
- Test sanguin de biochimie
- Biopsie
- Radiographie pulmonaire
- Formule sanguine complète (CBC)
- Consultation avec un immunologiste
- Consultation avec un hématologue pédiatrique
- Consultation avec un pédiatre
- Consultation avec un cardiologue
- Formule sanguine complète avec marqueurs de cancer et protéinogramme
- Électrocardiogramme
- Échocardiographie
- IRM de la tête
- TEP/TDM
- Сonsultation avec un oncohématologue
- Service infirmier 24h/24
- 3 repas par jour élaborés par un nutritionniste
Durée
- 30 jours à l'hôpital
Hébergement
Hospitalisation
Transport
Transfert aéroport-clinique-aéroport
Informations complémentaires
Pediatric Bone Marrow Transplant for Acute Lymphoblastic Leukemia (ALL)
Sheba Medical Center – Advanced, Personalized Care for Children
At Sheba Medical Center, we understand how overwhelming a diagnosis of Acute Lymphoblastic Leukemia (ALL) can be for both children and their families. Our mission is to provide not only the most advanced medical care available, but also reassurance, clarity, and compassionate support throughout every stage of treatment.
As a global leader in pediatric hemato-oncology, Sheba offers cutting-edge bone marrow transplantation (BMT) for children with ALL particularly in cases where the disease is high-risk, relapsed, or resistant to standard therapies.
When is a Bone Marrow Transplant Needed in ALL?
While many children with ALL respond very well to chemotherapy, some require a more intensive approach to achieve a lasting cure.
A bone marrow transplant may be recommended when:
The leukemia has relapsed
The disease is resistant to treatment
There are high-risk genetic features
A deeper, more durable remission is needed
In these situations, BMT replaces the diseased bone marrow with healthy stem cells helping rebuild a new immune system capable of eliminating leukemia cells.
A Personalized Treatment Strategy
Every child’s condition is unique. At Sheba, treatment decisions are made by a dedicated team of pediatric leukemia and transplant specialists who carefully tailor each plan.
Whenever possible, a matched sibling donor is used.
If no sibling match is available, we actively secure the most suitable donor using advanced matching technologies and global registries, including:
Matched unrelated donors from international donor programs
Haploidentical (half-matched) family donors, such as parents
Cord blood transplantation
Our state-of-the-art HLA and molecular laboratories ensure highly accurate matching, improving safety and transplant success.
Advanced Therapies for Better Outcomes
Sheba is at the forefront of innovation in pediatric ALL treatment, combining transplantation with the latest breakthroughs:
CAR-T cell therapy, often used before transplant in relapsed or refractory ALL to achieve remission
T-cell depletion and CD34+ selection reducing complications such as graft-versus-host disease
Access to international clinical trials and novel therapies
This integrated approach allows us to treat even the most complex cases successfully.
Leading Results in Pediatric ALL
Sheba’s outcomes for pediatric ALL are among the best internationally:
~70–85% success rates in children undergoing transplant in remission
Improved outcomes in relapsed cases through CAR-T integration
Strong long-term survival and quality of life
Our continuous research and clinical expertise ensure that every child benefits from the most advanced care available today.
Care That Supports the Whole Family
At Sheba, we treat more than the disease - we care for the child and their family as a whole. Children are treated in specialized, highly protected environments with advanced infection control, while families receive ongoing support, guidance, and clear communication.
Our team stays closely involved throughout the entire journey, ensuring each child is supported medically and emotionally on the path to recovery.
Why Families Choose Sheba for ALL Treatment
Global leader in pediatric leukemia and bone marrow transplantation
Expertise in high-risk and relapsed ALL
Ability to secure optimal donors even without a family match
Integration of CAR-T therapy and advanced cellular treatments
Multidisciplinary, patient-centered approach
Dedicated services for international families
A Message of Hope
For children facing Acute Lymphoblastic Leukemia, a bone marrow transplant can offer a real chance for cure. At Sheba Medical Center, we combine advanced science with compassionate care helping children overcome leukemia and move forward toward a healthy, hopeful future.
Assistance Bookimed 24/7
- Coordinateur médical personnel
- Organisation de voyage médical — réservation des tickets de vol et des chambres d'hôtel à des prix réduits pour les partenaires
- Prise en charge du patient lors d'un voyage médical
Prix du programme
Ce qui n'est PAS inclus dans ce forfait
Médecin
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Où en sommes-nous ?
À propos de la clinique
Le centre médical Sheba est l'un des meilleurs hôpitaux d'Israël et du monde. Le magazine Newsweek International a classé l' hôpital Sheba parmi les 10 meilleurs hôpitaux du monde en 2020. L'hôpital couvre 1 990 spécialités et plus de 1 500 000 patients du monde entier se rendent à l'hôpital Sheba pour se faire soigner chaque année.
Paiement et récompenses
Vous ne payez pas pour nos services
Vous effectuez votre paiement directement à la clinique ou sur leur compte bancaire officiel.
Certaines cliniques peuvent exiger un acompte dans le cadre de leur politique.
Étalez vos paiements avec des options de versements.
Gagnez des récompenses en parrainant vos amis sur Bookimed.